COVID-19 & Parkinson’s Disease
How is coronavirus (COVID-19) related to Parkinson’s? A new review paper titled INFLUENCE OF NOVEL CORONAVIRUS DISEASE (COVID-19) ON PARKINSON’S DISEASE: SYSTEMATIC REVIEW showed some interesting prelimiary findings on the relationship between Covid-19 infection and Parkinson’s disease (PD). While the paper has not been peer-reviewed or yet published, the initial findings found that people with […]
In the News: Dr. Isaacson
New Drug, SEP‑363856, Shows Promise in Helping with Parkinson’s Disease Psychosis Our Director, Dr. Stuart Isaacson, was quoted in a story by Parkinson’s News Today about a new drug candidate for Parkinson’s disease Psychosis, also referrred to as PDD. Click Here to read more or read our other blog post news articles for more information. […]
Podcast featuring Dr. Isaacson on Parkinson’s Clinical Trials
Volunteering for Parkinson’s Research: What to Know and Expect In this podcast interview, Dr. De León, a movement disorder specialist and Michael J. Fox Foundation Patient Council member leads a discussion with Dr. Stuart Isaacson about participating in Parkinson’s research. If you would like to learn more about new clinical research studies for Parkinson’s disease, […]
How to Keep Treatment Response “On” In Parkinson’s Disease
Can new drug classes and formulations help reduce breakthrough Parkinson’s activity? Dr. Stuart Isaacson was recently interviewed about a new treatment for Parkinson’s disease. Despite the past medical breakthrough of an orally available compound to replenish a diminished dopamine neurotransmitter in the brain, initial consistent therapeutic responses to levodopa in patients with Parkinson disease (PD) […]
Gala-at-Home 2020 to Benefit PAREF
The event was held on December 19, 2020 and was free to all online. A fundraising event to benefit the Parkinson’s & Alzheimer’s Research and Education Foundation (PAREF) was held online. The event aimed to raise awareness about Parkinson’s disease and Alzheimer’s disease in the area of lifestyle interventions and modifiable risk factors. The event […]